Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Vitamin D Supplementation in Relapsing-Remitting Multiple Sclerosis
2011-002785-20Phase 2Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of cholecalciferol in multiple sclerosis (MS) and clinically isolated syndrome (CIS), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Cumulative number of new hyperintense lesions in T2-weighted cranial MRI. Started Aug 2011; status: terminated.
02
Drugs
cholecalciferol
03
Conditions
multiple sclerosis (MS)clinically isolated syndrome (CIS)
Beyond the preview
Go deeper on 2011-002785-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002785-20.